Illumina

Illumina, Inc. develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function.

It provides a comprehensive line of genetic analysis solutions with products and services that serve a broad range of highly interconnected markets, including sequencing, genotyping, gene expression and molecular diagnostics.

Illumina’s goal is to apply innovative sequencing and array technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago.

Illumina’s array-based solutions for genomic analysis serve as tools for disease research, drug discovery, and the development of molecular tests in clinical labs.